本文认为,当前医药领域的问题在于,药方通过医生的处方绑定消费者后,就不用担心市场竞争,也就没有降价的市场压力。因此,医药与医疗间的利益链导致药价高企。由于在流通中产生了诸多可加价的环节,国家对药品零售店和医院采取的诸多限制药价措施收效甚微。为此,可采用孪生处方等措施缓解看病贵、药价高的难题。 This paper argues that the current problem in the pharmaceutical field is that after prescriptions are bound by consumers through prescriptions, doctors do not have to worry about market competition and there is no market pressure for price reduction. As a result, the chain of interest between medicine and healthcare leads to high drug prices. Due to the many links that can be raised in circulation, the measures taken by the state to restrict drug prices to pharmaceutical retailers and hospitals have had little effect. To this end, twin prescriptions and other measures can be used to ease the problem of expensive medical treatment and high prices.